07:00 , Aug 23, 2010 |  BC Week In Review  |  Company News

Blue Heron Biotechnology, OriGene deal

OriGene acquired gene synthesis company Blue Heron for an undisclosed sum. OriGene gains Blue Heron's GeneMaker DNA synthesis platform, as well as its variant and vector synthesis, custom cloning and sequence optimization services. OriGene, which...
07:00 , Apr 7, 2008 |  BC Week In Review  |  Company News

Blue Heron Biotechnology Inc., Codon Devices supply/service news

The companies settled a suit in which Codon alleged that Blue Heron infringed five patents covering DNA error correction technologies. Codon granted Blue Heron a perpetual, fully paid sublicense to the patents and released Blue...
07:00 , Mar 26, 2007 |  BC Week In Review  |  Company News

Blue Heron Biotechnology Inc., Codon Devices supply/service news

Codon filed a lawsuit in the U.S. District Court for the District of Delaware alleging that Blue Heron infringes Codon’s U.S. Patents Nos. 5,459,039; 5,556,750; 5,679,522; 5,702,894 and 5,750,335. The patents cover DNA error correction...
08:00 , Dec 18, 2006 |  BC Week In Review  |  Company News

Blue Heron Biotechnology Inc., Invitrogen deal

IVGN obtained exclusive worldwide rights to distribute Blue Heron's custom gene synthesis services. The companies also will co-develop undisclosed new products and services. IVGN will make an undisclosed investment in Blue Heron. Further terms were...
07:00 , May 28, 2002 |  BC Week In Review  |  Company News

Blue Heron Biotechnology Inc. board of directors update

Blue Heron Biotechnology Inc. , Bothell, Wash.   Business: Supply/Service   Appointed: Gregory Sessler, former SVP and CFO at Rosetta Inpharmatics Inc.  ...
07:00 , Jul 16, 2001 |  BC Week In Review  |  Company News

Amgen, Blue Heron Biotechnology Inc. deal

High throughput gene synthesis company Blue Heron licensed AMGN's U.S. Patent No. 4,652,639 covering a procedure for synthesizing linear double-stranded DNA. AMGN retains certain rights under the patent to use the technology internally. Amgen Inc....
07:00 , Jul 10, 2001 |  BC Extra  |  Company News

Blue Heron licenses Amgen patent

High throughput gene synthesis company Blue Heron Biotechnology (Bothell, Wash.) licensed AMGN's U.S. Patent No. 4,652,639 covering a procedure for synthesizing linear double-stranded DNA. AMGN retains certain rights to practice under the patent....
07:00 , Jun 4, 2001 |  BC Week In Review  |  Company News

Blue Heron Biotechnology Inc. sales and marketing update

Blue Heron launched its GeneMaker 1.0 platform for high throughput synthesis of genes, gene variants or DNA sequences. Blue Heron Biotechnology Inc., Bothell, Wash.   Business: Supply/Service  ...